Experts from across The Conversation assess the work that’s helped us reach vaccine roll-out, how this could play out, and the risk of vaccine hesitancy.
L’expertise universitaire, l’exigence journalistique
Articles sur Coronavirus insights
Affichage de 661 à 680 de 1079 articles
Calling out false information on social media may do more harm than good.
More patients die if there are fewer nurses available – so the UK must resolve its current shortage.
These countries forged their own path on coronavirus and attributed early successes to national character. Now they are facing more cases and deaths than ever.
Here’s what we still need to find out before we can know when we’ll be able to return to our pre-coronavirus ways.
Antibodies that go rogue and attack healthy tissue identified in patients with severe COVID.
The UK government has said that the rule allowing three households to mix this Christmas won’t change – but is this wise?
We find low taxes on the rich bring economies little benefit. This suggests there is a strong economic case for raising taxes on the rich to help repair public finances following the pandemic.
Counties, local authorities, councils – how you divvy up the map changes the game significantly.
SARS-CoV-2 mutates all the time, creating new variants. That doesn’t automatically mean it’s getting more harmful or better at spreading.
The UK government needs to show solidarity with the public.
Dutch parents worked more and had less leisure time – particularly if they were women.
We still need to know exactly what part of the immune response offers protection – and how strong it needs to be to remain protective.
🎧 PODCAST: An audio version of an in depth article by two doctors on what it’s like fighting COVID-19 the second time around.
The pandemic will have a long-term impact on life in the countryside.
Rituals have powerful effects on our emotions, allowing us to relive the happiness of Christmases past.
Two virologists give practical advice for reducing your exposure to COVID-19 this Christmas.
New research shows why the N protein might be a good target.
We need more data on the low-dose, high-dose regimen used in one arm of the trial, which may make the vaccine more effective.
Implausible theories give believers control over a puzzling and threatening world.
Les contributeurs les plus fréquents
-
Senior Research Fellow in Global Health, University of Southampton
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Medicine, University of East Anglia
-
Professor of Public Health, University of Sheffield
-
Lecturer in Psychology, Swansea University
-
Professor in Biomedical Sciences, University of Manchester
-
Professor of Mathematics and Statistics, University of Strathclyde
-
Associate Professor in Viral Immunology, University of Birmingham
-
Senior Lecturer in Mathematical Biology, University of Bath
-
Scientific Officer, University of Leeds
-
Principal Lecturer, Microbiology and Biomedical Science Practice, Fellow of the Institute of Biomedical Science, University of Brighton
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Clinical Research Fellow in Viral Immunology and Veterinary Surgeon, University of Cambridge
-
Assistant Professor in Health Promotion and Policy, UMass Amherst, UMass Amherst
-
Professor of Primary Care Health Sciences, University of Oxford
